Novo Nordisk A/S ADR (NVO)

$129.21 0.90 (0.70%)

19:00 EDT NVO Stock Quote Delayed 30 Minutes

Profit from the Panic: 3 Stocks to Pounce on When They Become Steals

By Rich Duprey, InvestorPlace Contributor May 1, 2024

We love it when our favorite clothes go on sale, so when the market offers us a deal, these are the stocks to buy on dips.

3 of Europe’s ‘Magnificent 18’ Stocks That You Can Buy in the U.S.

3 Biotech Stocks With Skyrocketing Potential: April 2024

3 Biotech Stocks Set to Double by 2028

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 5.22M

Day's Range $127.50 - $130.13

52-Week Range $75.56 - $138.28

Dividend & Yield $1.77 (1.37%)

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

From InvestorPlace
From the Web

3 Pharma Stocks That Are Money-Printing Machines in 2024

By Michael Que, InvestorPlace Contributor Apr 15, 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

By Louis Navellier and the InvestorPlace Research Staff Apr 12, 2024

We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.

Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027

By Chris MacDonald, InvestorPlace Contributor Apr 12, 2024

For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.

All-Time High Flyers: 7 Stocks to Buy as the Market Peaks

By Joel Baglole, InvestorPlace Contributor Apr 11, 2024

These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

By Shane Neagle, InvestorPlace Contributor Apr 10, 2024

Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments

3 Underappreciated Healthcare Stocks to Buy Now: April 2024

By Terel Miles, InvestorPlace Contributor Apr 3, 2024

Novo Nordisk (NVO), United Therapeutics (UTHR) and Vertex Pharmaceuticals (VRTX) are three underappreciated healthcare stocks to buy in April.

Hedge Fund Favorites: 3 European Stocks Attracting Significant U.S. Investment

By Joel Baglole, InvestorPlace Contributor Apr 3, 2024

Investors looking for diversification should consider these European names that are increasingly popular among hedge fund managers.

Knocking on the Trillion-Dollar Door: 3 Stocks Ready to Shatter the Market Cap Milestone

By Joey Frenette, InvestorPlace Contributor Mar 28, 2024

The trillion-dollar market cap club could fill with some high-momentum large-caps that could give the Magnificent Seven a good run.

3 Healthcare Stocks to Buy From 3 of the Best Actively Managed Funds

By Will Ashworth, InvestorPlace Contributor Mar 28, 2024

Although the performance of these three healthcare stocks has been inconsistent in 2024, they remain undervalued.

3 Stocks to Buy for the Next Bull Run: March 2024

By Joel Baglole, InvestorPlace Contributor Mar 26, 2024

With all three major stock indices currently at all-time highs, it's natural to wonder what's next for equities and if the bull run can continue? According to analysts at Goldman Sachs, the bulls are likely to continue stampeding across Wall Street.

Hot Stocks: The 3 Best Opportunities for Investing in Biotech

By Chandler Capital, InvestorPlace Contributor Mar 21, 2024

Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.

7 Stocks That Are Creating a Buzz on Wall Street

By Joel Baglole, InvestorPlace Contributor Mar 21, 2024

Buy these stocks creating buzz in order to inject some green into your portfolio and give your investment returns a boost.

3 Biopharma Stocks Predicted to Soar in Q2 2024

By Joel Lim, InvestorPlace Contributor Mar 20, 2024

These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.

3 GRANOLAS Stocks to Buy for Serious Growth

By Joey Frenette, InvestorPlace Contributor Mar 19, 2024

The GRANOLAS stocks are full of incredible growth stocks that may not get nearly as much love as the Magnificent Seven plays these days.

7 Mega-Cap Stocks That Can Turn $10,000 Into $1 Million

By Alex Sirois, InvestorPlace Contributor Mar 15, 2024

These million dollar mega cap stocks will continue to produce big winners in 2024 and beyond as they continue to rise.

3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold

By Chris Markoch, InvestorPlace Contributor Mar 15, 2024

If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.

On the Dip: 3 Stocks to Snatch Up Whenever the Market Stumbles

By Vandita Jadeja Mar 11, 2024

Build a solid portfolio with stocks that shine through all seasons. Here are the stocks to buy the dip each time the market stumbles.

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

By Josh Enomoto, InvestorPlace Contributor Mar 10, 2024

The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last…

The Top 3 Pharma Stocks to Buy in March 2024

By Shane Neagle, InvestorPlace Contributor Mar 9, 2024

Investors explore the top three biotechnology stocks to buy in 2024, which are leading the anti-obesity market surge.

NVO Stock Alert: Novo Nordisk Pops on New Weight-Loss Drug

By William White, InvestorPlace Writer Mar 7, 2024

Novo Nordisk stock is gaining on Thursday as NVO investors react to positive news from its new weight loss drug clinical trial.

Novo Nordisk A/S ADR (NVO)

Profit from the Panic: 3 Stocks to Pounce on When They Become Steals

3 of Europe’s ‘Magnificent 18’ Stocks That You Can Buy in the U.S.

3 Biotech Stocks With Skyrocketing Potential: April 2024

3 Biotech Stocks Set to Double by 2028

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novo Nordisk A/S ADR (NVO)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

Subscriber Sign in